A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

Not Applicable

Completed

• Conditions: Medication Adherence

• Registration Number: NCT05150028
• Lead Sponsor: Roswell Park Cancer Institute

Brief Summary

To develop a cancer center level practice intervention to promote treatment adherence and reduce outcome disparities in pediatric cancer survivors

Detailed Description

To conduct a pilot study to assess the feasibility and acceptability of the Social Determinants of Adherence intervention

Study Timeline

• Study First Submitted: 2021-11-24
• Study First Submitted QC: 2021-12-06
• Study First Posted: 2021-12-08
• Study Start: 2023-04-11
• Primary Completion: 2023-06-06
• Study Completion: 2024-06-06
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-16
• Last Update Posted: 2024-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

Parents/caregivers of pediatric patients must meet the following criteria to be eligible:

• Parents/guardians of child that has been diagnosed with any cancer.
• Parents/guardians of child with any cancer between age 0 and 18.
• Parents/guardians of child on home-based oral anti-cancer therapy or supportive care therapy.
• The clinician for the family agrees to participate in the study.

Exclusion Criteria

• Participants will be excluded from this study if unwilling or unable to complete the assessment in English

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Retention rates	Up to 8 weeks	Feasibility of intervention as assessed by retention rates

Secondary Outcome Measures

Name	Time	Method
Feasibility of universal SDOA screening	up to 8 weeks	Will be assessed by results of SDOA questionnaire an 8 item questionnaire rated on a 5-point Likert scale (0-I never experienced this ; 5 - I experience this quite a lot)
Provider satisfaction with barrier reports	up to 8 weeks	REDCap analytics will track the rate of opened barrier reports

Trial Locations

Locations (1)

Roswell Park Cancer Institute; 🇺🇸 Buffalo, New York, United States